92 related articles for article (PubMed ID: 12771948)
1. Alteration of the PATCHED locus in superficial bladder cancer.
Aboulkassim TO; LaRue H; Lemieux P; Rousseau F; Fradet Y
Oncogene; 2003 May; 22(19):2967-71. PubMed ID: 12771948
[TBL] [Abstract][Full Text] [Related]
2. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
3. [The PATCHED/Sonic Hedgehog signalling pathway in superficial bladder cancer].
LaRue H; Simoneau M; Aboulkassim TO; Lemieux P; Girard J; Hamed S; Hovington H; Jeannotte L; Fradet Y
Med Sci (Paris); 2003 Oct; 19(10):920-5. PubMed ID: 14613000
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
[TBL] [Abstract][Full Text] [Related]
5. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
Habuchi T; Devlin J; Elder PA; Knowles MA
Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
[TBL] [Abstract][Full Text] [Related]
6. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
7. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
8. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
9. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
10. Accelerated induction of bladder cancer in patched heterozygous mutant mice.
Hamed S; LaRue H; Hovington H; Girard J; Jeannotte L; Latulippe E; Fradet Y
Cancer Res; 2004 Mar; 64(6):1938-42. PubMed ID: 15026327
[TBL] [Abstract][Full Text] [Related]
11. Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma.
Shen T; Park WS; Böni R; Saini N; Pham T; Lash AE; Vortmeyer AO; Zhuang Z
Hum Pathol; 1999 Mar; 30(3):284-7. PubMed ID: 10088546
[TBL] [Abstract][Full Text] [Related]
12. The random development of LOH on chromosome 9q in superficial bladder cancers.
van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
[TBL] [Abstract][Full Text] [Related]
13. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
14. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC.
Habuchi T; Yoshida O; Knowles MA
Hum Mol Genet; 1997 Jun; 6(6):913-9. PubMed ID: 9175739
[TBL] [Abstract][Full Text] [Related]
15. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
Keen AJ; Knowles MA
Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
[TBL] [Abstract][Full Text] [Related]
16. Patched acts catalytically to suppress the activity of Smoothened.
Taipale J; Cooper MK; Maiti T; Beachy PA
Nature; 2002 Aug; 418(6900):892-7. PubMed ID: 12192414
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
18. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]